Speakers, Kathleen Wyne, MD, PhD, FACE, FNLA, George Grunberger, MD, FACP, FACE, and Felice Caldarella, MD, FACP, CDE, FACE, discuss the significant improvements in accuracy of Continuous Glucose Monitor (CGM) sensors and device algorithms that have made CGM-based treatment decisions a current reality. The program also evaluates the clinical application of CGM in diabetes management decisions and the importance of various aspects of CGM to guide optimal treatment, regardless of insulin mode of administration.
Thursday, May 17, 2018, 5:15am- 7:30am
Sheraton Boston Hotel, Constitution Ballroom A-B, Level 2
39 Dalton St, Boston, Massachusetts
Our Chairman and CEO, Kevin Sayer, was on Mad Money with Jim Cramer to discuss our CGM technology and the successful year Dexcom had in 2018.
November is National Diabetes Awareness Month, a time when communities across the country bring attention to the impact and treatment of diabetes.